Trial ID or NCT#
NCT02341560
Status
NOT RECRUITING
Purpose
This study will determine the effect of QPI-1007 on visual function in subjects with recent-onset NAION and assess the safety and tolerability of intravitreal injections of QPI-1007 in this population. This study will also evaluate the structural changes in the retina following administration of QPI-1007.
Official Title
A Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 Delivered By Single or Multi-Dose Intravitreal Injection(s) to Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Eligibility Criteria
Ages Eligible for Study: 50 Years to 80 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Investigator(s)
Y. Joyce Liao, MD, PhD
Professor of Ophthalmology and of Neurology
Shannon Beres, MD
Neuro-ophthalmology specialist,
General neurologist
Clinical Assistant Professor, Neurology & Neurological Sciences
Clinical Assistant Professor, Ophthalmology
Heather E. Moss, MD, PhD
Neuro-ophthalmology specialist
Associate Professor of Ophthalmology and of Neurology
Theodore Leng, MD, FACS
Ophthalmologist
Associate Professor of Ophthalmology and, by courtesy, of Anesthesiology, Perioperative and Pain Medicine (Adult MSD)
Contact us to find out if this trial is right for you.
CONTACT
Mariana Nunez
(650) 497-7846
View on ClinicalTrials.gov